Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. View recommended dosing for ELIQUIS in the following indications: NVAF. Reduction in risk of stroke/systemic embolism in NVAF. DVT/PE. Treatment of DVT/PE & reduction in risk of recurrence following initial therapy. HIP/KNEE. Prophylaxis of DVT, which may lead to PE, after hip or knee replacement surgery.

  2. 31 lip 2024 · The recommended dose of ELIQUIS is 2.5 mg twice daily in patients with at least two of the following characteristics: •. age greater than or equal to 80 years. •. body weight less than or equal to 60 kg. •. serum creatinine greater than or equal to 1.5 mg/dL.

  3. For patients receiving ELIQUIS doses of 5 mg or 10 mg twice daily, reduce the dose of ELIQUIS by 50% when ELIQUIS is coadministered with drugs that are combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, or ritonavir). In patients already taking 2.5 mg twice daily, avoid coadministration of ELIQUIS with combined P-gp ...

  4. podawania produktu Eliquis i VKA należy oznaczyć wskaźnik INR przed następnym zaplanowanym podaniem dawki produktu Eliquis. Jednoczesne podawanie produktu Eliquis i VKA należy kontynuować do czasu, aż wartość wskaźnika INR wyniesie ≥ 2. Pacjenci w podeszłym wieku

  5. 15 sie 2024 · Detailed Apixaban dosage information for adults. Includes dosages for Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism and more; plus renal, liver and dialysis adjustments.

  6. Zalecana dawka produktu ELIQUIS to 2,5 mg, przyjmowana doustnie, dwa razy na dobę. Pierwszą dawkę należy zażyć 12-24 godziny po zabiegu chirurgicznym.

  7. 29 wrz 2014 · The recommended dose is one 2.5 mg tablet taken by mouth twice a day, usually for over one month (32 to 38 days) after a hip replacement or for 10 to 14 days after a knee replacement. For patients with atrial fibrillation at risk of stroke or blood clots, the recommended dose is 5 mg taken twice a day.

  1. Ludzie szukają również